Axitinib as a third or further line of treatment in renal cancer: a single institution experience

被引：0
作者：
G. Tsironis
M. Liontos
A. Kyriazoglou
K. Koutsoukos
A. Tsiara
M. Kaparelou
R. Zakopoulou
A. Cohen
E. Skafida
S. Fontara
F. Zagouri
A. Bamias
M. A. Dimopoulos
机构：
[1] Alexandra Hospital,Oncology Unit, Department of Clinical Therapeutics
[2] Aretaieio University hospital,1st Department of Radiology
来源：
BMC Urology | / 20卷
关键词：
Axitinib;beyond second line; mRCC; Long responders; TKIs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 238 条
  • [31] Davis ID(undefined)undefined undefined undefined undefined-undefined
  • [32] Mardiak J(undefined)undefined undefined undefined undefined-undefined
  • [33] Szczylik C(undefined)undefined undefined undefined undefined-undefined
  • [34] Lee E(undefined)undefined undefined undefined undefined-undefined
  • [35] Wagstaff J(undefined)undefined undefined undefined undefined-undefined
  • [36] Barrios CH(undefined)undefined undefined undefined undefined-undefined
  • [37] Salman P(undefined)undefined undefined undefined undefined-undefined
  • [38] Gladkov OA(undefined)undefined undefined undefined undefined-undefined
  • [39] Kavina A(undefined)undefined undefined undefined undefined-undefined
  • [40] Escudier B(undefined)undefined undefined undefined undefined-undefined
12345678910